Cargando…

Broad Neutralization of SARS-CoV-2 Variants, Including Omicron, following Breakthrough Infection with Delta in COVID-19-Vaccinated Individuals

Numerous studies have shown that a prior SARS-CoV-2 infection can greatly enhance the antibody response to COVID-19 vaccination, with this so called “hybrid immunity” leading to greater neutralization breadth against SARS-CoV-2 variants of concern. However, little is known about how breakthrough inf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lechmere, Thomas, Snell, Luke B., Graham, Carl, Seow, Jeffrey, Shalim, Zayed A., Charalampous, Themoula, Alcolea-Medina, Adela, Batra, Rahul, Nebbia, Gaia, Edgeworth, Jonathan D., Malim, Michael H., Doores, Katie J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040729/ https://www.ncbi.nlm.nih.gov/pubmed/35297676 http://dx.doi.org/10.1128/mbio.03798-21

Ejemplares similares

Broad and potent neutralizing antibodies are elicited in vaccinated individuals following Delta/BA.1 breakthrough infection
por: Seow, Jeffrey, et al.
Publicado: (2023)

SARS-CoV-2 variants with shortened incubation periods necessitate new definitions for nosocomial acquisition
por: Snell, Luke B, et al.
Publicado: (2022)

Descriptive comparison of admission characteristics between pandemic waves and multivariable analysis of the association of the Alpha variant (B.1.1.7 lineage) of SARS-CoV-2 with disease severity in inner London
por: Snell, Luke B, et al.
Publicado: (2022)

Rapid genome sequencing in hospitals to identify potential vaccine-escape SARS-CoV-2 variants
por: Snell, Luke B, et al.
Publicado: (2021)

Feasibility and clinical utility of local rapid Nanopore influenza A virus whole genome sequencing for integrated outbreak management, genotypic resistance detection and timely surveillance
por: Williams, Tom G. S., et al.
Publicado: (2023)

Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study
por: Pickering, Suzanne, et al.
Publicado: (2021)

Real-Time Whole Genome Sequencing to Guide Patient-Tailored Therapy of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Snell, Luke B, et al.
Publicado: (2022)

Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 infection early in the pandemic and the role of unidentified cases in transmission
por: Snell, Luke B., et al.
Publicado: (2022)

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
por: Dupont, Liane, et al.
Publicado: (2021)

Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections
por: Dupont, Liane, et al.
Publicado: (2021)

The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern
por: Graham, Carl, et al.
Publicado: (2022)

Delta breakthrough infections elicit potent, broad and durable neutralizing antibody responses
por: Walls, Alexandra C., et al.
Publicado: (2021)

Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants
por: Zhao, Hanjun, et al.
Publicado: (2022)

Protection Against Breakthrough Delta/Omicron Variants in Vaccinated Patients with Myeloproliferative Neoplasms (MPN)
por: Barbui, Tiziano, et al.
Publicado: (2022)

Endogenous antibody responses in REGN-COV2-treated SARS-CoV-2-infected individuals
por: Kurshan, Ashwini, et al.
Publicado: (2023)

SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USA
por: Keyel, Alexander C., et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Breakthrough Infections of Omicron and Delta Variants in Healthcare Workers
por: Regenhardt, Elisa, et al.
Publicado: (2023)

Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants
por: Servellita, Venice, et al.
Publicado: (2022)

Breakthrough cases of Omicron and Delta variants of SARS-CoV-2 during the fifth wave in Pakistan
por: Jamal, Zunera, et al.
Publicado: (2022)

Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa
por: Goga, Ameena, et al.
Publicado: (2022)

Antibody titres in fully vaccinated healthcare workers with and without breakthrough infection during the Delta and Omicron waves
por: Chandrasingh, Sindhulina, et al.
Publicado: (2023)

Evaluating the potential for respiratory metagenomics to improve treatment of secondary infection and detection of nosocomial transmission on expanded COVID-19 intensive care units
por: Charalampous, Themoula, et al.
Publicado: (2021)

Vaccine breakthrough infections with SARS-CoV-2 Alpha mirror mutations in Delta Plus, Iota, and Omicron
por: Martínez-González, Brenda, et al.
Publicado: (2022)

Humoral Response in Hemodialysis Patients Following COVID-19 Vaccination and Breakthrough Infections during Delta and Omicron Variant Predominance
por: Chinnadurai, Rajkumar, et al.
Publicado: (2022)

Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections
por: Stærke, Nina Breinholt, et al.
Publicado: (2022)

Vaccine‐breakthrough infection by the SARS‐CoV‐2 omicron variant elicits broadly cross‐reactive immune responses
por: Zhou, Runhong, et al.
Publicado: (2022)

Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5
por: Bormann, Maren, et al.
Publicado: (2023)

Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
por: Søraas, Arne, et al.
Publicado: (2022)

Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: Results from a pilot service implemented during the first pandemic wave
por: Sweeney, Nicola, et al.
Publicado: (2021)

A trifunctional peptide broadly inhibits SARS-CoV-2 Delta and Omicron variants in hamsters
por: Zhao, Hanjun, et al.
Publicado: (2022)

P990: T CELL RESPONSE AND OMICRON VARIANT NEUTRALISATION FOLLOWING VACCINATION AGAINST SARS-COV-2 IN PATIENTS WITH CHRONIC MYELOID DISORDERS
por: Harrington, P., et al.
Publicado: (2022)

Omicron breakthrough infections in vaccinated or previously infected hamsters
por: Zhou, Jie, et al.
Publicado: (2023)

Translational Research in the Time of COVID-19—Dissolving Boundaries
por: Edgeworth, Jonathan D., et al.
Publicado: (2020)

Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralization in patients with chronic myeloid disorders
por: Harrington, Patrick, et al.
Publicado: (2022)

Comparative neutralization profiles of naive and breakthrough infections with Delta, Omicron BA.1 and BA.2 variants of SARS-CoV-2
por: Yang, Yang, et al.
Publicado: (2022)

RNA loads of severe acute respiratory syndrome coronavirus 2 in patients with breakthrough coronavirus disease 2019 caused by the Delta and Omicron variants
por: de Michelena, Paula, et al.
Publicado: (2023)

Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
por: Yamamoto, Shohei, et al.
Publicado: (2023)

Erratum: Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
Publicado: (2023)

Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination
por: Chi, Xiangyang, et al.
Publicado: (2022)

Omicron BQ.1 and BQ.1.1 escape neutralisation by omicron subvariant breakthrough infection
por: Jiang, Xiao-Lin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6fjmlunbt0ug7p818ee36ml2ie